GlassScriptPhysician profile
Haley H Walton
NPI 1952779696
$755.95
in general payments reported to CMS, 2019-2025
12 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $145 · 2022: $17.51 · 2023: $301 · 2024: $145 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $593.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $208.34 | 2023 | Puraply |
| Pacira Therapeutics, INC. | $124.49 | 2021 | |
| Miach Orthopaedics, INC. | $113.01 | 2024 | |
| Davol INC. | $107.06 | 2023-2025 | |
| Orthofix Medical, INC. | $33.78 | 2025 | Physio-Stim |
| Genentech USA, INC. | $32.17 | 2024 | Actemra |
| Zimmer Biomet Holdings, INC. | $27.88 | 2025 | Comprehensive Shoulder System |
| Ferring Pharmaceuticals INC. | $25.85 | 2025 | Euflexxa |
| Lightbody Medical Technologies INC | $23.06 | 2025 | |
| Sanofi-Aventis U.S. LLC | $22.15 | 2023 | |
| Heron Therapeutics, INC. | $20.65 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $17.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Walton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.